Why Did SoFi Stock Drop?
Fintech platform SoFi (NASDAQ:SOFI) has stumbled in recent days, selling…
Sell
43
SNGX Quote, Financials, Valuation and Earnings
Last price:
$1.61
Seasonality move
:
36.3%
Day range:
$1.49 - $1.67
52-week range:
$1.09 - $6.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
2.14x
Volume:
790.6K
Avg. volume:
290K
1-year change:
-49.69%
Market cap:
$16.2M
Revenue:
--
EPS (TTM):
-$3.66
Analysts' Opinion
-
Consensus RatingSoligenix, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 1 Buy rating, 0 Hold ratings, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $17.50, Soligenix, Inc. has an estimated upside of 986.96% from its current price of $1.61.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $10.00 representing 100% downside risk from its current price of $1.61.
Fair Value
-
According to the consensus of 1 analyst, Soligenix, Inc. has 986.96% upside to fair value with a price target of $17.50 per share.
SNGX vs. S&P 500
-
Over the past 5 trading days, Soligenix, Inc. has overperformed the S&P 500 by 0.94% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Soligenix, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Soligenix, Inc. revenues have been falling on a year-over-year basis for 2 quarters in a row. In the most recent quarter Soligenix, Inc. reported revenues of --.
Earnings Growth
-
Soligenix, Inc. has grown year-over-year earnings for 13 quarters straight. In the most recent quarter Soligenix, Inc. reported earnings per share of -$0.58.
Enterprise value:
6.1M
EV / Invested capital:
--
Price / LTM sales:
--
EV / EBIT:
--
EV / Revenue:
--
PEG ratio (5yr expected):
--
EV / Free cash flow:
-0.63x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
-$3.3K
Return On Assets:
-129.48%
Net Income Margin (TTM):
--
Return On Equity:
-248.07%
Return On Invested Capital:
-207.14%
Operating Margin:
-1703.62%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $200K | -- | -- | -- | -- | |
| Gross Profit | -$464.4K | -$347.3K | -$3.3K | -$1.6K | -$900 | |
| Operating Income | -$9.9M | -$8.2M | -$12.4M | -$1.9M | -$2.6M | |
| EBITDA | -$9.8M | -$8.2M | -$12.4M | -$1.9M | -$2.6M | |
| Diluted EPS | -$32.70 | -$7.80 | -$3.66 | -$0.78 | -$0.58 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $29.4M | $17.5M | $11M | $10.2M | $10.9M | |
| Total Assets | $29.7M | $17.9M | $11.3M | $10.5M | $11.3M | |
| Current Liabilities | $4.8M | $9.7M | $5.5M | $4.5M | $3.4M | |
| Total Liabilities | $14.7M | $16.9M | $7.1M | $4.5M | $3.7M | |
| Total Equity | $15.1M | $1M | $4.2M | $5.9M | $7.6M | |
| Total Debt | $9.9M | $10.1M | $3.1M | $2.1M | $273.9K | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | -$10.4M | -$8M | -$9.8M | -$2.9M | -$2.9M | |
| Cash From Investing | -- | -- | -$3.9K | -- | -$600 | |
| Cash From Financing | $3.8M | $7.5M | $10.5M | $3.3M | $8.4M | |
| Free Cash Flow | -$10.4M | -$8M | -$9.8M | -$2.9M | -$2.9M | |
SNGX
Sector
Market Cap
$16.2M
$28.5M
Price % of 52-Week High
25.84%
51.44%
Dividend Yield
0%
0%
Shareholder Yield
-105.14%
-1.33%
1-Year Price Total Return
-49.69%
-20.32%
Beta (5-Year)
1.834
0.520
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Buy
Level
$1.55
200-day SMA
Sell
Level
$1.98
Bollinger Bands (100)
Sell
Level
1.25 - 2.83
Chaikin Money Flow
Sell
Level
-306.3M
20-day SMA
Buy
Level
$1.44
Relative Strength Index (RSI14)
Buy
Level
56.70
ADX Line
Buy
Level
19.16
Williams %R
Sell
Level
-14.6341
50-day SMA
Buy
Level
$1.48
MACD (12, 26)
Buy
Level
0.01
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
792.4M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (-38.6921)
Sell
CA Score
(Annual)
Level (-5.7298)
--
Beneish M-Score
(Annual)
Level (--)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (7.4678)
--
Piotroski F Score
(Annual)
Level (--)
Sell
Quality Ratio Score
Level (2)
Sell
Fundamental Score
Level (2)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Soligenix, Inc. is a late-stage biopharmaceutical company, which engages in the development and commercialization of products to treat rare diseases. It operates through the Specialized BioTherapeutics and Public Health Solutions segments. The Specialized BioTherapeutics segment focuses on the development of a novel photodynamic therapy (SGX301) utilizing topical synthetic hypericin activated with safe visible fluorescent light for the treatment of cutaneous T-cell lymphoma. The Public Health Solutions segment consists of active development programs for RiVax, a ricin toxin vaccine candidate, and SGX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease. The company was founded in 1987 and is headquartered Princeton, NJ.
Stock Forecast FAQ
In the current month, SNGX has received 1 Buy ratings 0 Hold ratings, and 0 Sell ratings. The SNGX average analyst price target in the past 3 months is $17.50.
-
Where Will Soligenix, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Soligenix, Inc. share price will rise to $17.50 per share over the next 12 months.
-
What Do Analysts Say About Soligenix, Inc.?
Analysts are divided on their view about Soligenix, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Soligenix, Inc. is a Sell and believe this share price will drop from its current level to $10.00.
-
What Is Soligenix, Inc.'s Price Target?
The price target for Soligenix, Inc. over the next 1-year time period is forecast to be $17.50 according to 1 Wall Street analyst, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is SNGX A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Soligenix, Inc. is a Buy. 1 of 1 analysts rates the stock a Buy at this time.
-
How Can I Buy Shares Of SNGX?
You can purchase shares of Soligenix, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Soligenix, Inc. shares.
-
What Is The Soligenix, Inc. Share Price Today?
Soligenix, Inc. was last trading at $1.61 per share. This represents the most recent stock quote for Soligenix, Inc.. Yesterday, Soligenix, Inc. closed at $1.61 per share.
-
How To Buy Soligenix, Inc. Stock Online?
In order to purchase Soligenix, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get SNGX Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
SNGX
Sector
P/E ratio
--
23.75x
PEG ratio
--
-0.01x
P/B ratio
2.14x
1.83x
Price / LTM sales
--
1.60x
Growth Metrics
SNGX
Sector
Revenue growth
-54.5%
4.85%
Earnings growth
25.06%
11.11%
Revenue (5-year growth)
-100%
6.45%
Earnings forecast
-$0.26
-$0.20
Profitability
SNGX
Sector
Profitability FY 2024
-$125.2K
$3.6M
Return on invested capital
-207.14%
-30.98%
Return on assets
-129.48%
-27.62%
Return on equity
-248.07%
-36.69%
Earnings Date
Last Earnings Date
Aug
10
Next Earnings Date
Dec
8
Estimated Next Earnings Date
Mar
9
Balance Sheet
SNGX
Sector
Total cash
$10.5M
$27.2M
Short term investments
--
$25.7M
Total assets
$9M
$79.7M
Long term debt
$273.9K
$4.1M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Will Robinhood Win AI Investing?
Recently, online brokerage Robinhood (NASDAQ:HOOD) has been focused on introducing…
Is Amazon an AI Stock?
With the market starting to look skittish on pure-play AI…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.4T
P/E Ratio: 62x
Buy
56
Is AAPL Stock a Buy?
Market Cap: $4.1T
P/E Ratio: 37x
Buy
81
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
56
SMX alert for Dec 6
SMX (Security Matters) Plc [SMX] is up 134.09% over the past day.
Buy
62
PRAX alert for Dec 6
Praxis Precision Medicines, Inc. [PRAX] is up 30.47% over the past day.
Sell
13
PSN alert for Dec 6
Parsons Corp. [PSN] is down 21.1% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
